Practical and concise synthesis of nucleoside analogs

被引:0
作者
Emma K. Davison
David A. Petrone
Michael Meanwell
Matthew B. Nodwell
Steven M. Silverman
Louis-Charles Campeau
Robert Britton
机构
[1] Simon Fraser University,Department of Chemistry
[2] Merck & Co.,Department of Process Research and Development
[3] Inc.,undefined
来源
Nature Protocols | 2022年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Nucleoside analogs are valuable commodities in the development of antisense oligonucleotides or as stand-alone antiviral and anticancer therapies. Syntheses of nucleoside analogs are typically challenged by a reliance on chiral pool starting materials and inefficient synthetic routes that are not readily amenable to diversification. The novel methodology described in this protocol addresses several longstanding challenges in nucleoside analog synthesis by enabling flexible and selective access to nucleoside analogs possessing variable nucleobase substitution, D- or L-configuration, selective protection of C3′/C5′ alcohols and C2′ or C4′ derivatizations. This protocol provides direct access to C3′/C5′ protected nucleoside analogs in three steps from simple, achiral starting materials and is described on both research (2.8 g) and process (30 g) scales for the synthesis of C3′/C5′-acetonide protected uridine. Using this protocol, proline catalyzes the fluorination of simple heteroaryl-substituted aldehyde starting materials, which are then directly engaged in a one-pot enantioselective aldol reaction with a dioxanone. Reduction, followed by intramolecular annulative fluoride displacement, forges the nucleoside analog. The three-step parent protocol can be completed in ~5 d by using simple mix-and-stir reaction procedures and standard column chromatographic purification techniques.
引用
收藏
页码:2008 / 2024
页数:16
相关论文
共 12 条
[1]  
Shelton J(2016)Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs Chem. Rev. 116 14379-14455
[2]  
Quemener AM(2020)The powerful world of antisense oligonucleotides: from bench to bedside Wiley Interdiscip. Rev. RNA 11 e1594-1652
[3]  
Kim J(2019)Patient-customized oligonucleotide therapy for a rare genetic disease N. Engl. J. Med. 381 1644-929
[4]  
McLaughlin M(2017)Enantioselective synthesis of 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) via enzymatic desymmetrization Org. Lett. 19 926-5903
[5]  
Peifer M(2014)A general and enantioselective approach to pentoses: a rapid synthesis of PSI-6130, the nucleoside core of sofosbuvir J. Am. Chem. Soc. 136 5900-730
[6]  
Berger R(2020)A short de novo synthesis of nucleoside analogs Science 369 725-undefined
[7]  
Shurtleff VW(2020)Unifying the synthesis of nucleoside analogs Science 369 623-undefined
[8]  
Conrad JC(2021)Diversity-oriented synthesis of glycomimetics Commun. Chem. 4 96-undefined
[9]  
MacMillan DWC(undefined)undefined undefined undefined undefined-undefined
[10]  
Meanwell M(undefined)undefined undefined undefined undefined-undefined